Dr. Liron Bar-Peled of the Massachusetts General Hospital Cancer Center is recipient of funding from the the Evan Schumacher Fund for Rare Cancer Research at TargetCancer Foundation. In this video, Dr. Bar-Peled discusses his work identifying his creative strategies for identifying new targets for treatment in cholangiocarcinoma and other difficult to treat cancers.
- About
- About TCF
- Our Impact
- Our Team
- Partners & Collaborators
- News & Updates
- Frequently Asked Questions
- Financials
- Learn
- Rare Cancer Resources
- What is a Rare Cancer?
- Initial Steps After a Rare Cancer Diagnosis
- Biomarker Testing in Rare Cancers
- Clinical Trials
- Video Library
- Glossary
- Research
- Events
- TCF Events
- TargetCancer Foundation Gala
- A Night to Strike Out Rare Cancer
- Webinars
- Scientific Meetings
- Boston Marathon
- Rare Cancer Day
- Get Involved
- Blog
- Contact